logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Selver Işık

department of medical oncology
H指数:7
被引数:163

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Baseline and Early On-Treatment Prognostic Nutritional Index in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer Treated with CDK4/6 Inhibitors

基线和早期治疗中的预后营养指数在激素受体阳性、HER2阴性转移性乳腺癌患者中的应用（接受CDK4/6抑制剂治疗）

Journal of Clinical Medicine
IF2.9
2026-09-020
OA
Ezgi Çoban; Atilla Eren Kurt; Fırat Akagündüz; Ahmet Demirel; Mustafa Alperen Tunç; Burak Paçacı; Ali Kaan Güren; Erkam Kocaaslan; Pınar Erel; Yeşim Ağyol; Abdussamet Çelebi; Selver Işık; Nazım Can Demircan; Osman Köstek; İbrahim Vedat Bayoğlu; Murat Sarı
Digital health engagement and health literacy among cancer patients: a cross-sectional study of ICT usage patterns

癌症患者数字健康参与度和健康素养：一项关于ICT使用模式的横断面研究

BMC Health Services Research
IF3
2026-08-210
OAAI
Abdussamet Çelebi; Nur Aybüke Bircan; Nadiye Sever; Ali Kaan Güren; Yeşim Ağyol; Erkam Kocaaslan; Pınar Erel; Burak Paçacı; Nargiz Majidova; Mustafa Alperen Tunç; Fırat Akagündüz; Ahmet Demirel; Selver Işık; Ezgi Çoban; Nazım Can Demircan; İbrahim Vedat Bayoğlu; Osman Köstek; Murat Sarı
Prognostic impact of the Gustave Roussy Immune score in metastatic renal cell carcinoma treated with first-line immunotherapy-based combinations: results from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)

Gustave Roussy免疫评分对接受一线免疫疗法为基础的联合治疗转移性肾细胞癌的预后影响：土耳其肿瘤学组肾癌联盟（TKCC）的研究结果

BMC Cancer
IF3.4
2026-08-060
OA
Aysun Fatma Akkuş; Hatice Bölek; Esma Kaplan Tüzün; Elif Serteşen Camöz; Safa Can Efil; Murad Guliyev; Selver Işık; Caner Kapar; Serhat Sekmek; Halil Göksel Güzel; Sercan Ön; Sema Sezin Göksu; Özlem Nuray Sever; Çagatay Arslan; Nuri Karadurmuş; Musfafa Özgüroğlu; Mehmet Ali Nahit Sendur; Deniz Tural; Muhammet Bekir Hacıoğlu; Emre Yekedüz; Yüksel Ürün
Long-Term Outcomes and Conditional Recurrence-Free Survival in Stage II Colon Cancer: The Impact of Surveillance and Recurrence Detection Strategies

II期结肠癌的长期结局与条件无复发生存率：监测和复发检测策略的影响

Journal of Clinical Medicine
IF2.9
2026-06-240
OA
Mustafa Alperen Tunç; Ali Kaan Güren; Burak Paçacı; Fırat Akagündüz; Erkam Kocaaslan; Ahmet Demirel; Yeşim Ağyol; Pınar Erel; Nargiz Majidova; Nadiye Sever; Naz Tayyar Tunç; Nazım Can Demircan; Selver Işık; Abdussamed Çelebi; Ezgi Çoban; Osman Köstek; İbrahim Vedat Bayoğlu; Murat Sarı
Prognostic value of nutritional and inflammation-based scores in advanced soft tissue sarcoma treated with trabectedin: a multicenter study

晚期软组织肉瘤接受曲贝替定治疗后营养和炎症评分的预后价值：一项多中心研究

Frontiers in Oncology
IF3.3
2026-04-230
OA
SJ Seda Jeral Evinç; ÇE Çağla Eyüpler Akmercan; SC Selin Cebeci; ZB Zeliha Birsin; İN İsmail Nazlı; AK Ali Kaan Güren; SI Selver Işık; BK Bahadır Köylü; İD İlknur Deliktaş Onur; TA Tugay Atasever; TK Tuğba Kaya; EÇ Emir Çerme; MG Murat Günaltılı; BP Berrin Papila; NS Nebi Serkan Demirci; ÇP Çiğdem Papila; ÖA Özkan Alan
Determinants of survival after neoadjuvant chemotherapy in resectable gastric cancer: adjuvant dose intensity, radiotherapy, and pathologic response

可切除胃癌新辅助化疗后生存的影响因素：辅助剂量强度、放射治疗和病理反应

Expert Review of Anticancer Therapy
IF2.8
2026-04-130
PRE
Özgecan Dülgar Kaya; Ayberk Bayramgil; Ahmet Bilici; Erdem Sünger; Tuğba Kaya; Tuğba Başoğlu Tüylü; Tuba Baydaş; Sinan Koca; Yeşim Ağyol; Selver Işık; Burçin Çakan Demirel; Vedat Buğra Erol; Nilufer Bulut; Busra Niğdelioğlu; Melike Özçelik
Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

评估以贝伐珠单抗为基础的治疗在复发性原发性脑肿瘤中的有效性和耐受性：一项多中心真实世界土耳其肿瘤学会（TOG）研究

BMC Cancer
IF3.4
2026-02-140
OAAI
Zehra Sucuoğlu İşleyen; Şaban Seçmeler; Abdullah Sakin; Şener Cihan; Mehmet Beşiroğlu; Seda Kahraman; Melek Karakurt Eryılmaz; Esra Zeynelgil; Eda Çalışkan Yıldırım; Engin Kut; Nilay Şengül; Fatma Paksoy Türköz; Özkan Alan; Özlem Özkul; Selver Işık; Feride Yılmaz; Ahmet Gülmez; Sema Türker; Gökhan Karakaya; Meral Günaldı; Leyla Özer; Asude Aksoy; Fatih Karataş; Teoman Sakalar; Derya Demirtaş Esmer; Fatih Teker; Necla Demir; Özgecan Dülgar; Serdar Turhal; Hacı Mehmet Türk; Kayhan Ertürk; Emir Çelik; M. Mustafa Atcı
Prognostic Value of 18F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab
Journal of Clinical Medicine
IF2.9
2026-01-260
OAAI
Erkam Kocaaslan; Ali Kaan Güren; Fırat Akagündüz; Ahmet Demirel; Mustafa Alperen Tunç; Burak Paçacı; Yeşim Ağyol; Pınar Erel; Abdüssamed Çelebi; Selver Işık; Ezgi Çoban; Nazım Can Demircan; Salih Özgüven; Zeynep Ceren Balaban Genç; Nargiz Majidova; Nadiye Sever; Murat Sarı; Osman Köstek; Ibrahim Vedat Bayoğlu
Prognostic role of smoking in metastatic renal cell carcinoma in real-world data from the Turkish Oncology Group Kidney Cancer Consortium (TKCC)
Scientific Reports
IF3.9
2026-01-170
OAAI
Hatice Bolek; Elif Sertesen Camoz; Omer Faruk Kuzu; Hilal Karakas; Saadet Sim; Serhat Sekmek; Selver Isık; Murat Günaltılı; Aysun Fatma Akkus; Halil Göksel Güzel; Deniz Tural; Cagatay Arslan; Sema Sezin Goksu; Ozlem Nuray Sever; Nuri Karadurmus; Cengiz Karacin; Mustafa Özgüroğlu; Mehmet Ali Nahit Sendur; Emre Yekedüz; Yuksel Urun
Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab

接受尼鲁单抗治疗转移性非小细胞肺癌患者治疗相关体成分变化的预后价值

Medicina-Lithuania
IF2.4
2026-01-020
OAAI
Kocaaslan, Erkam; Guren, Ali Kaan; Akagunduz, Firat; Demirel, Ahmet; Tunc, Mustafa Alperen; Pacaci, Burak; Agyol, Yesim; Erel, Pinar; Celebi, Abdussamed; Isik, Selver; Coban, Ezgi; Demircan, Nazim Can; Ozguven, Salih; Balaban Genc, Zeynep Ceren; Majidova, Nargiz; Sever, Nadiye; Sari, Murat; Kostek, Osman; Bayoglu, Ibrahim Vedat
Uric acid level in metastatic renal cell carcinoma treated with nivolumab: a Turkish Oncology Group Kidney Cancer Consortium (TKCC) study

尿酸盐水平在转移性肾细胞癌接受纳武利尤单抗治疗中的研究：一项土耳其肿瘤学组肾癌联盟（TKCC）研究

immunotherapy
IF2.3
2025-07-030
PRE
Serhat Sekmek; Hatice Bolek; Omer Faruk Kuzu; Elif Sertesen Camoz; Saadet Sim; Hilal Karakaş; Murad Guliyev; Aysun Fatma Akkus; Selver Isık; Gökhan Uçar; Deniz Tural; Cagatay Arslan; Sema Sezin Goksu; Ozlem Nuray Sever; Nuri Karadurmus; Cengiz Karacin; Mehmet Ali Nahit Sendur; Emre Yekedüz; Yüksel Ürün
The impact of smoking on nivolumab outcomes in renal cell carcinoma: real-world data from the Turkish Oncology Group Kidney Cancer Consortium

吸烟对纳武利尤单抗治疗肾细胞癌结局的影响：土耳其肿瘤学组肾癌联盟的真实世界数据

ONCOLOGIST
IF4.2
2025-07-010
PRE
Camoz, Elif Sertesen; Bolek, Hatice; Kuzu, Omer Faruk; Sim, Saadet; Karakas, Hilal; Sekmek, Serhat; Guliyev, Murad; Akkus, Aysun Fatma; Isik, Selver; Tural, Deniz; Arslan, Cagatay; Goksu, Sema Sezgin; Sever, Ozlem Nuray; Karadurmus, Nuri; Karacin, Cengiz; Ozguroglu, Mustafa; Sendur, Mehmet Ali Nahit; Yekeduz, Emre; Urun, Yuksel
Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium

在转移性肾细胞癌中 navigat ing二线疗法：免疫检查点抑制剂与酪氨酸激酶抑制剂的比较分析：土耳其肿瘤学组肾癌联盟的研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-04-240
OA
Musa Barış Aykan; Hatice Bölek; Emre Yekedüz; Elif Sertesen; Deniz Tural; Cengiz Karaçin; Mehmet Ali Nahit Şendur; Gökhan Uçar; Çağatay Arslan; Selver Işık; Saadet Sim; Özlem Nuray Sever; Bekir Hacıoğlu; Sema Sezgin Göksu; Mustafa Özgüroğlu; Nuri Karadurmuş; Yüksel Ürün
Prognostic Factors in High Grade Osteosarcoma Patients Who Received Neoadjuvant Therapy and Subsequently Underwent Surgery: Data from the Turkish Oncology Group
JOURNAL OF CLINICAL MEDICINE
IF2.9
2025-03-170
OAAI
Sever, Nadiye; Simsek, Fatih; Onur, Ilknur Deliktas; Arvas, Hayati; Guliyev, Tural; Sakalar, Teoman; Cicek, Ceren Mordag; Orman, Seval; Cetin, Emine Bihter; Kayas, Kamil; Akbas, Sinem; Agyol, Yesim; Guren, Ali Kaan; Erel, Pinar; Kocaaslan, Erkam; Pacaci, Burak; Tunc, Mustafa Alperen; Celebi, Abdussamet; Majidova, Nargiz; Durnali, Ayse; Simsek, Melih; Sahbazlar, Mustafa; Isik, Selver; Arikan, Rukiye; Ercelep, Ozlem; Sari, Murat; Kostek, Osman; Bayogu, Ibrahim Vedat
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium

舒尼替尼在转移性肾细胞癌中的应用：土耳其肿瘤学组肾癌协作组中不同风险组的临床结局

CANCER COMMUNICATIONS
IF24.9
2025-02-101
OAAI
Bolek, Hatice; Kuzu, Omer Faruk; Sertesen Camoz, Elif; Sim, Saadet; Sekmek, Serhat; Karakas, Hilal; Isik, Selver; Guliyev, Murad; Akkus, Aysun Fatma; Tural, Deniz; Arslan, Cagatay; Goksu, Sema Sezin; Sever, Ozlem Nuray; Karadurmus, Nuri; Karacin, Cengiz; Sendur, Mehmet Ali Nahit; Yekeduez, Emre; Urun, Yuksel
Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors
JOURNAL OF CLINICAL MEDICINE
IF2.9
2025-02-070
OAAI
Guren, Ali Kaan; Guliyev, Murad; Alan, Ozkan; Cadirci, Kivanc; Belevi, Ipek Naz; Gulturk, Ilkay; Ozge, Emre; Kocaaslan, Erkam; Agyol, Yesim; Erel, Pinar; Pacaci, Burak; Tunc, Mustafa Alperen; Majidova, Nargiz; Sever, Nadiye; Celebi, Abdussamet; Arikan Erdogan, Rukiye; Isik, Selver; Demirci, Nebi Serkan; Sari, Murat; Kostek, Osman; Bayoglu, Ibrahim Vedat
Treatment outcomes and prognostic factors in patients with driver mutant non-small cell lung cancer and de novo brain metastases
SCIENTIFIC REPORTS
IF3.9
2024-03-093
OAAI
Kahraman, Seda; Karakaya, Serdar; Kaplan, Muhammed Ali; Goksu, Sema Sezgin; Ozturk, Akin; Isleyen, Zehra Sucuoglu; Hamdard, Jamshid; Yildirim, Sedat; Dogan, Tolga; Isik, Selver; Celebi, Abdussamet; Gulbagci, Burcu Belen; Paksoy, Nail; Dogan, Mutlu; Turk, Haci Mehmet; Bilici, Ahmet; Tatli, Ali Murat; Akbas, Sinem; Turan, Nedim; Hacibekiroglu, Ilhan; Dogu, Gamze Gokoz; Aydiner, Adnan; Sumbul, Ahmet Taner; Akyurek, Serap; Yalciner, Merih; Demirkazik, Ahmet; Gursoy, Pinar; Aykan, Musa Baris; Sahin, Elif; Karadag, Ibrahim; Kostek, Osman; Er, Muhammed Muhiddin; Artac, Mehmet; Duzkopru, Yakup; Aydin, Dincer; Isik, Deniz; Karakas, Yusuf; Kilickap, Saadettin; Erol, Cihan; Demir, Bilgin; Civelek, Burak; Ergun, Yakup; Akinci, Muhammed Bulent; Dogan, Izzet; Karadurmus, Nuri; Yumuk, Perran Fulden; Sendur, Mehmet Ali Nahit

研究方向

暂未获取到该数据
İ
İbrahim Vedat Bayoğlu
H 指数:21论文数:150被引数:1,331
A
Abdüssamet Çelebi
H 指数:6论文数:46被引数:144
Y
Yeşim Ağyol
H 指数:3论文数:35被引数:31
E
Erkam Kocaaslan
H 指数:3论文数:43被引数:30
M
Murat Sarı
H 指数:16论文数:144被引数:726
M
Mustafa Alperen Tunç
H 指数:2论文数:23被引数:20
M
Mehmet Alı Nahıt Şendur
H 指数:27论文数:429被引数:4,152
N
Nuri Karadurmuş
H 指数:25论文数:278被引数:1,788
N
Nargız Majidova
H 指数:6论文数:77被引数:103
P
Pınar Erel
H 指数:3论文数:34被引数:33